Abstracts Archive - Page 1719 of 2607 - ACR Meeting Abstracts

Abstract Number: 1798 • 2016 ACR/ARHP Annual Meeting
Risk Factors for Osteonecrosis in Systemic Lupus Erythematosus: A Systematic Review
Sara Hussein¹, Manon Suitner¹, Alexandra Baril-Dionne¹, Mihaela Luminita Popescu¹, Nancy Santesso², Stephanie O. Keeling³, Janet E. Pope⁴, Aurore Fifi-Mah⁵ and Josiane Bourré-Tessier¹, ¹Université de Montréal, Montreal, QC, Canada, ²McMaster University, Hamilton, ON, Canada, ³University of Alberta, Edmonton, AB, Canada, ⁴University of Western Ontario, London, ON, Canada, ⁵University of Calgary, Calgary, AB, Canada
Background/Purpose: Non-traumatic osteonecrosis (ON) is a well-recognized complication in systemic lupus erythematosus (SLE). The reported symptomatic ON prevalence is 10-15% and as high as 44%…
Abstract Number: 1799 • 2016 ACR/ARHP Annual Meeting
Smoking, Antiphospholipid Antibodies and Thrombosis in SLE
Michelle Petri¹, George Stojan² and Wei Fu³, ¹Rheumatology Division, Johns Hopkins University School of Medicine, Baltimore, MD, ²Rheumatology, Johns Hopkins University, Baltimore, MD, ³Division of Rheumatology, School of Medicine, Johns Hopkins University, Baltimore, MD
Background/Purpose: Anticardiolipin Ever smoking 411 (48.1%) Past smoking 246 (49.8%) Current smoking 165 (46.6%) Never smoking 721 (48.9%) P Value (Ever vs. Never) 0.6943…
Abstract Number: 1800 • 2016 ACR/ARHP Annual Meeting
Prevalence of ECG Cardiovascular Abnormalities in Lupus Patients: A Novel Approach Using 5 ECG Elements
Hanan Al Rayes¹, Paula Harvey², Dafna D Gladman³, Arthy Sabapathy¹, Murray Urowitz¹ and Zahi Touma¹, ¹Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ²Cardiology, Women's College Hospital, University of Toronto, Toronto, ON, Canada, ³University of Toronto, Toronto, ON, Canada
Background/Purpose: Lupus patients are at increased risk for cardiovascular disease (CVD). Chou et al. (Ann Inter Med 2011) found that resting ECG abnormalities, in particular…
Abstract Number: 1801 • 2016 ACR/ARHP Annual Meeting
Clinical Implications of Persistent Sinus Tachycardia in Systemic Lupus Erythematous: A Retrospective Study
Santosh Bhusal¹, Bassam Alhaddad², Douglas Einstadter³ and Stanley Ballou¹, ¹Rheumatology, Case Western Reserve University/MetroHealth Medical Center, Cleveland, OH, ²Rheumatology, Premier Physicians, Westlake OH, Cleveland, OH, ³Medicine, Case Western Reserve University/MetroHealth Medical Center, Cleveland, OH
Background/Purpose: Resting Sinus Tachycardia (ST) is found in approximately 50 % of patients with SLE. Unexplained episodes of intermittent ST could be a manifestation of…
Abstract Number: 1802 • 2016 ACR/ARHP Annual Meeting
Prevalence of CMV in the Ohio State University Lupus Population
Brian LaMoreaux¹, Alexa Meara², Holly Steigelman³, Juliette Yedimenko⁴, Wael N. Jarjour⁵ and Stacy P. Ardoin⁶, ¹Rheumatology, Fellow, Columbus, OH, ²Internal Medicine/Rheumatology, The Ohio State University, Columbus, OH, ³The Ohio State University, Columbus, OH, ⁴S2056, The Ohio State University, Columbus, OH, ⁵Department of Rheumatology/Medicine, Ohio State University, Columbus, OH, ⁶Pediatric & Adult Rheumatology, Ohio State University, Columbus, OH
Background/Purpose: Systemic Lupus Erythematous (SLE) is a clinically variable autoimmune disease occurring predominantly in women of childbearing age. SLE treatment can range from close clinical…
Abstract Number: 1803 • 2016 ACR/ARHP Annual Meeting
General Features of SLE Patients Presenting with Autoimmune Hemolytic Anemia
Regaip Elezi¹, Gulsum Emel Pamuk², Muhammet Maden², Mehmet Ali Balci^1,3 and Omer Nuri Pamuk¹, ¹Rheumatology, Trakya University Medical Faculty, Edirne, Turkey, ²Hematology, Trakya University Medical Faculty, Edirne, Turkey, ³Department of Rheumatology, Trakya University Medical Faculty, Edirne, Turkey
Background/Purpose: Anemia in systemic lupus erythematosus (SLE) might have various etiologies; however, autoimmune hemolytic anemia (AIHA) is the characteristic hematologic feature. AIHA might be primary…
Abstract Number: 1804 • 2016 ACR/ARHP Annual Meeting
Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus: a Single Centre Experience
Konstantinos Tselios¹, Dafna D Gladman² and Murray Urowitz³, ¹Medicine, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ²University of Toronto, Toronto, ON, Canada, ³Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada
Background/Purpose: Pulmonary arterial hypertension (PAH) is detected in 0.5-17.5% of patients with systemic lupus erythematosus (SLE). Systemic inflammation may play a dominant role in its…
Abstract Number: 1805 • 2016 ACR/ARHP Annual Meeting
Factors Associated with Complete Remission in Patients with Systemic Lupus Erythematosus: A Retrospective Cohort Study in One Center
Jorge Romo-Tena¹, Diana Gómez-Martín¹, Roberto Reyna², Isaac Bartnicki-Navarrete³ and Jorge Alcocer-Varela¹, ¹Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, ²Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, ³Internal Medicine, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
Background/Purpose: Systemic lupus erythematosus (SLE) is characterized by disease flares, alternated with periods of clinical remission. In the past years, the “treat-to-target” strategy in SLE…
Abstract Number: 1806 • 2016 ACR/ARHP Annual Meeting
Adherence to Treatment and Social, Educational Levels in Patients with Systemic Lupus Erythematosus
Raul Sueldo¹, Maria Constanza Bertolaccini², Ramiro Maldonado¹, Julia Romero³, Luciana Gonzalez Lucero⁴, Maximiliano Machado Escobar¹, Liliana Galindo⁵, Mirta Santana¹ and Eleonora Lucero¹, ¹Hospital Angel Cruz Padilla, Tucumán, Argentina, ²Rheumatology, Hospital Angel Cruz Padilla, Tucumán, Argentina, ³Rheumatology Service, Rheumatology Service, Hospital Británico, Buenos Aires, Buenos Aires, Argentina, ⁴Rheumatology Unit, Hospital Padilla, Tucumán, Tucumán, Argentina, ⁵Hospital Ángel Cruz Padilla, Tucuman, Argentina
Background/Purpose: To assess adherence to treatment in patients with Systemic Lupus Erythematosus (SLE) and to determine its relationship with social, educational levels and disease activity.…
Abstract Number: 1807 • 2016 ACR/ARHP Annual Meeting
Prevalence of Progressive Multifocal Leukoencephalopathy in Adults and Children with Systemic Lupus Erythematosus
Pooja Mahadeshwar¹, Teja Kapoor¹, Kayla Quinnies², Nicholas Tatonetti², Joyce Hui-Yuen³, Samantha Nguyen¹, Joan Bathon¹, Kayla Neville¹, James Miceli¹, Stacy Tanner⁴ and Anca Askanase¹, ¹Rheumatology, Columbia University Medical Center, New York, NY, ²Biomedical Informatics, Columbia University Medical Center, NY, NY, ³North Shore-Long Island Jewish Health System, Lake Success, NY, ⁴Rheumatology, Columbia University Medical Center, NY, NY
Background/Purpose: In the era of powerful immunosuppression, opportunistic infections are an increasing concern in Systemic Lupus Erythematosus (SLE). A potentially fatal opportunistic demyelinating disease of…
Abstract Number: 1808 • 2016 ACR/ARHP Annual Meeting
Frequency and Factors Associated with Thirty Day Hospital Readmissions Among Systemic Lupus Erythematosus Patients in a Community Hospital in the California Central Valley
Candice Yuvienco¹, Ololade Oladimeji², Ashenafi Legesse² and Paul Mills², ¹Internal Medicine, Division of Rheumatology, University of California San Francisco, Fresno Medical Education Program, Fresno, CA, ²Internal Medicine, University of California San Francisco, Fresno Medical Education Program, Fresno, CA
Background/Purpose: Systemic Lupus Erythematosus (SLE) is a chronic autoimmune condition which has one of the highest rates of hospital readmissions in the United States. There…
Abstract Number: 1809 • 2016 ACR/ARHP Annual Meeting
Influence of Solar Radiation in Cutaneous Manifestations of Lupus: Data from the Gladel Cohort
Marina Scolnik¹, Luis J. Catoggio¹, Enrique R. Soriano¹, Daniel Wojdyla², Alejandro Alvarellos³, Nilzio A Da Silva⁴, Eduardo Ferreira Borba⁵, Emilia Sato⁶, Antonio Iglesias-Gamarra⁷, Marlene Guibert-Toledano⁸, Sergio Jacobelli⁹, Ignacio Garcia de la Torre¹⁰, Maria Josefina Sauza del Pozo¹¹, Eduardo M. Acevedo-Vásquez¹², Maria H Esteva-Spinetti¹³, Graciela S. Alarcon¹⁴ and Bernado Pons-Estel¹⁵, ¹Rheumatology Section, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, ²GLADEL consultant, Rosario, Argentina, ³Hospital Privado de Córdoba, Servicio de Reumatologia, Cordoba, Argentina, ⁴Faculdade de Medicina da Universidade Federal de Goiás, Goiania, Brazil, ⁵Rheumatology, Hospital das Clinicas, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil, ⁶Rheumatology Div/Dept of Med, Escola Paulista de Medicina - Universidade Federal de São Paulo, Sao Paulo, Brazil, ⁷Facultad de Medicina, Universidad del Bosque, Bogota, Colombia, ⁸Centro de Investigaciones Médico Quirúrgicas, Habana, Centro de Investigaciones Médico Quirúrgicas, Habana, La Habana, Cuba, ⁹Medicine / Rheumatology, Pontificia Universidad Catolica de Chile, Santiago, Chile, ¹⁰Hospital General de Occidente, Guadalajara, Mexico, ¹¹Servicio de Reumatología, Instituto Mexicano de Seguro Social, Hospital de Especialidades Nº 25, Monterrey, Mexico, ¹²Hospital Nacional Guillermo Almenara Irigoyen, Lima, Peru, ¹³Unidad de Reumatología, Hospital Central de San Cristóbal, San Cristobal, Venezuela (Bolivarian Republic of), ¹⁴Department of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ¹⁵Sanatorio Parque, Rosario, Argentina
Background/Purpose: Classically, it has been thought that sun exposure is a risk factor for developing cutaneous manifestations in Systemic Lupus Erythematosus. On the other hand,…
Abstract Number: 1810 • 2016 ACR/ARHP Annual Meeting
Health Care Utilization Preceding Diagnosis of Systemic Lupus Erythematosus in Youth
Joyce Chang¹, Colleen Brensinger², Liu Qing² and Andrea Knight^1,3,4, ¹Division of Pediatric Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA, ²Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA, ³Center for Pediatric Clinical Effectiveness, Children's Hospital of Philadelphia, Philadelphia, PA, ⁴PolicyLab, Children's Hospital of Philadelphia, Philadelphia, PA
Background/Purpose: Early diagnosis and treatment of youth with SLE are crucial to prevent organ damage and reduce mortality. Understanding health care utilization prior to diagnosis…
Abstract Number: 1811 • 2016 ACR/ARHP Annual Meeting
Systemic Lupus Erythematosus: Detailed Anatomy of a Cohort (follow-up for more than 35 years).
Borja Del Carmelo Gracio Tello¹, Alexis Jones¹, Charles Raine¹ and David Isenberg², ¹Rheumatology, University College Hospital, London, London, United Kingdom, ²University College Hospital, London, London, United Kingdom
Background/Purpose: Very long-term follow-up has rarely been reported in lupus patients. We report on the follow up of (up to 37 years) of our lupus…
Abstract Number: 1812 • 2016 ACR/ARHP Annual Meeting
Impact of Severe Organic CNS Involvement in Cognitive Function in a Cohort of Systemic Lupus Erythematosus Patients
Christina V. Golemati¹, Eleni Kampylafka¹, Charalampos Papageorgiou², Panayiotis G Vlachoyiannopoulos¹ and Athanasios G. Tzioufas³, ¹Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece, ²1st Psychiatry, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece, ³School of Medicine, Pathophysiology Department, National and Kapodistrian University of Athens, Athens, Greece
Background/Purpose: Our purpose was to investigate cognitive dysfunction (CD) in a cohort of Neuropsychiatric Systemic Lupus Erythematosus (NPSLE) patients (n=16) with severe central nervous system…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].